TI
XGN icon

Trexquant Investment’s Exagen XGN Stock Holding History

Trexquant Investment’s Portfolio XGN Stock Details XGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-33,394
Closed -$100K – 2278
2026
Q1 		$100K Sell
33,394
-22,215
-40% -$85.9K ﹤0.01% 1703
2025
Q4 		$338K Buy
55,609
+44,504
+401% +$405K ﹤0.01% 1424
2025
Q3 		$122K Buy
+11,105
New +$98.4K ﹤0.01% 1534

Other funds holding XGN

WC
Wexford Capital West Palm Beach, Florida $782M AUM 62.56% 1-Year Est. Return
NCNMGF
Nano-Cap New Millennium Growth Fund Staten Island, New York $130M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
FCM
FourWorld Capital Management New York $110M AUM 44.07% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $15.3B AUM 40.56% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return
MBAM
Mink Brook Asset Management West Palm Beach, Florida $227M AUM 64.76% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

Trexquant Investment's XGN Position: Q2 2026 in Review

Trexquant Investment sold out of Exagen (XGN) in Q2 2026, closing a stake of 33,394 shares — an estimated $100K sold.

Trexquant Investment first reported a position in XGN in Q3 2025 and held it in 3 quarters. The position peaked at $338K in Q4 2025. 57 funds tracked by Wall St. Rank hold XGN as of Q2 2026.

  • Trexquant Investment reported no remaining Exagen position as of Q2 2026 after selling out during the quarter.
  • Trexquant Investment sold 33,394 Exagen shares in Q2 2026, an estimated $100K.
  • Trexquant Investment first reported a position in Exagen in Q3 2025 and held it in 3 quarters.
  • Trexquant Investment's Exagen position peaked at $338K in Q4 2025.
  • 57 funds tracked by Wall St. Rank held Exagen as of Q2 2026.

Based on Trexquant Investment's 13F filing for Q2 2026, filed 14 Aug 2026.